量表提供了识别非酒精性脂肪性肝病患者生活方式干预依从性的可能性。
Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease.
机构信息
Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
出版信息
World J Gastroenterol. 2024 Jul 7;30(25):3179-3181. doi: 10.3748/wjg.v30.i25.3179.
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder, and dietary and lifestyle interventions remain the mainstays of NAFLD therapy. Zeng established a prediction system to evaluate adherence to lifestyle interventions in patients with NAFLD and choose optimal management. Here, we discuss the application scenarios of the scale and the areas warranting further attention, aiming to provide a possible reference for clinical recommendations.
非酒精性脂肪性肝病 (NAFLD) 是最常见的慢性肝脏疾病，饮食和生活方式干预仍然是 NAFLD 治疗的主要方法。曾建立了一个预测系统来评估 NAFLD 患者对生活方式干预的依从性，并选择最佳管理方案。在这里，我们讨论了该量表的应用场景和需要进一步关注的领域，旨在为临床推荐提供可能的参考。
Zotero 插件